Physician profile
Nancy Birner
NPI 1043214778
$1,418.89
in general payments reported to CMS, 2019-2025
15 companies · $395 in 2025
The $395 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $92.09 · 2021: $12.56 · 2022: $64.44 · 2023: $358 · 2024: $254 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $496.36 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Pfizer INC. | $202.70 | 2019-2025 | |
| Novo Nordisk INC | $198.47 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Kowa Pharmaceuticals America, INC. | $145.90 | 2019-2020 | |
| Exact Sciences Corporation | $86.04 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Lilly USA, LLC | $84.02 | 2023-2025 | Mounjaro, Kisunla, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $36.66 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.10 | 2023-2024 | Jardiance, Synjardy, Tradjenta |
| Sanofi Pasteur INC. | $31.64 | 2019 | |
| Allergan, INC. | $21.76 | 2020 | |
| Dexcom, INC. | $18.98 | 2023 | Dexcom G6 Transmitter |
| Amgen INC. | $17.50 | 2023 | Otezla, Repatha |
| Tris Pharma INC | $16.82 | 2023 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $16.37 | 2025 | Bexsero, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Birner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.